Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer

Lung cancer remains one of the leading causes of cancer-related deaths worldwide with a 5-year survival rate of less than 20%. One approach to improving survival is the identification of biomarkers to detect early stage disease. In this study, we investigated the potential of the stem cell and progenitor cell marker, Musashi1 (Msi1), as a diagnostic marker and potential therapeutic target for lung cancer. Functional studies in A549 bronchioalveolar carcinoma and NCI-H520 squamous cell carcinoma cells revealed that Msi1 was enriched in spheroid cultures of tumor cells and in the CD133+ cell population. Downregulation of Msi1 by lentivirus-mediated expression of an Msi1 shRNA reduced spheroid colony proliferation. Growth inhibition was associated with reduced nuclear localization of β-catenin and inhibition of the processing of intracellular Notch. In primary lung cancer, Msi1 protein expression was elevated in 86% of 202 tissue microarray specimens, and Msi1 mRNA was increased in 80% of 118 bronchoscopic biopsies, including metastatic disease, but was rarely detected in adjacent normal lung tissue and in non-malignant diseased tissue. Msi1 was expressed in a diffuse pattern in most tumor subtypes, except in squamous cell carcinomas, where it appeared in a focal pattern in 50% of specimens. Thus, Msi1 is a sensitive and specific diagnostic marker for all lung cancer subtypes.

[1]  P. Northcott,et al.  The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis. , 2012, The American journal of pathology.

[2]  H. Devaraj,et al.  Aberrant expression of CD133 and musashi‐1 in preneoplastic and neoplastic human oral squamous epithelium and their correlation with clinicopathological factors , 2012, Head & neck.

[3]  Hideyuki Okano,et al.  RNA-Binding Protein Musashi1 Modulates Glioma Cell Growth through the Post-Transcriptional Regulation of Notch and PI3 Kinase/Akt Signaling Pathways , 2012, PloS one.

[4]  M. Gorospe,et al.  The Oncogenic RNA-Binding Protein Musashi1 Is Regulated by HuR via mRNA Translation and Stability in Glioblastoma Cells , 2012, Molecular Cancer Research.

[5]  Tao Yu,et al.  Musashi1 expression cells derived from mouse embryonic stem cells can be enriched in side population isolated by fluorescence activated cell sorter , 2011, BMC Cell Biology.

[6]  M. Salto‐Tellez,et al.  Sequential expression of putative stem cell markers in gastric carcinogenesis , 2011, British Journal of Cancer.

[7]  Dawei Li,et al.  Msi-1 is a Predictor of Survival and a Novel Therapeutic Target in Colon Cancer , 2011, Annals of Surgical Oncology.

[8]  D. Wigle.  Personalized therapy for non-small cell lung cancer: hype or clinical reality? , 2011, Seminars in thoracic and cardiovascular surgery.

[9]  K. Neufeld,et al.  Novel Double-negative Feedback Loop between Adenomatous Polyposis Coli and Musashi1 in Colon Epithelia* , 2011, The Journal of Biological Chemistry.

[10]  Julien Nadjar,et al.  The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through Wnt and Notch activation , 2010, Journal of Cell Science.

[11]  H. Okano,et al.  New insight into cancer therapeutics: Induction of differentiation by regulating the Musashi/Numb/Notch pathway , 2010, Cell Research.

[12]  Hideyuki Okano,et al.  Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival , 2010, Molecular Cancer.

[13]  H. Okano,et al.  Neural RNA-Binding Protein Musashi1 Controls Midline Crossing of Precerebellar Neurons through Posttranscriptional Regulation of Robo3/Rig-1 Expression , 2010, Neuron.

[14]  J. Jett,et al.  Advances in the diagnosis of lung cancer: contribution of molecular biology to bronchoscopic diagnosis , 2010, Current opinion in pulmonary medicine.

[15]  M. Gonen,et al.  Progenitor stem cell marker expression by pulmonary carcinomas , 2010, Modern Pathology.

[16]  Curtis C. Harris,et al.  Microenvironmental modulation of asymmetric cell division in human lung cancer cells , 2010, Proceedings of the National Academy of Sciences.

[17]  L. Mariani,et al.  Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment , 2009, Proceedings of the National Academy of Sciences.

[18]  C. Vogel,et al.  A comprehensive in silico expression analysis of RNA binding proteins in normal and tumor tissue; identification of potential players in tumor formation , 2009, RNA biology.

[19]  H. Okano,et al.  3′‐Untranslated region of doublecortin mRNA is a binding target of the Musashi1 RNA‐binding protein , 2009, FEBS letters.

[20]  G. Weinmaster,et al.  Numb Regulates Post-endocytic Trafficking and Degradation of Notch1* , 2009, The Journal of Biological Chemistry.

[21]  S. Le,et al.  Genomic Analyses of Musashi1 Downstream Targets Show a Strong Association with Cancer-related Processes* , 2009, Journal of Biological Chemistry.

[22]  L. O. Penalva,et al.  Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy , 2008, BMC Cancer.

[23]  R. Glazer,et al.  Musashi1: A stem cell marker no longer in search of a function , 2008, Cell cycle.

[24]  L. Kiesel,et al.  Increased expression of the adult stem cell marker Musashi‐1 in endometriosis and endometrial carcinoma , 2008, The Journal of pathology.

[25]  G. Silvestri,et al.  Bronchoscopy for the diagnosis and staging of lung cancer. , 2008, Seminars in respiratory and critical care medicine.

[26]  H. Okano,et al.  Neural RNA-binding protein Musashi1 inhibits translation initiation by competing with eIF4G for PABP , 2008, The Journal of cell biology.

[27]  H. McLeod,et al.  Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo. , 2008, Gastroenterology.

[28]  H. Okano,et al.  Musashi1 Modulates Mammary Progenitor Cell Expansion through Proliferin-Mediated Activation of the Wnt and Notch Pathways , 2008, Molecular and Cellular Biology.

[29]  M. Biffoni,et al.  Identification and expansion of the tumorigenic lung cancer stem cell population , 2008, Cell Death and Differentiation.

[30]  S. Lippman,et al.  Molecular signatures of lung cancer--toward personalized therapy. , 2007, The New England journal of medicine.

[31]  M. Katoh,et al.  NUMB is a break of WNT-Notch signaling cycle. , 2006, International journal of molecular medicine.

[32]  R. Nusse,et al.  Wnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors* , 2006, Journal of Biological Chemistry.

[33]  Jane Mitchell,et al.  The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1 , 2006, Molecular and Cellular Neuroscience.

[34]  H. Okano,et al.  Function of RNA-binding protein Musashi-1 in stem cells. , 2005, Experimental cell research.

[35]  C. McGlade,et al.  Mammalian Numb Proteins Promote Notch1 Receptor Ubiquitination and Degradation of the Notch1 Intracellular Domain* , 2003, Journal of Biological Chemistry.

[36]  K. Mikoshiba,et al.  The Neural RNA-Binding Protein Musashi1 Translationally Regulates Mammalian numb Gene Expression by Interacting with Its mRNA , 2001, Molecular and Cellular Biology.

[37]  H. Okano,et al.  Musashi1: An Evolutionally Conserved Marker for CNS Progenitor Cells Including Neural Stem Cells , 2000, Developmental Neuroscience.

[38]  L. Penalva,et al.  Musashi1: an RBP with versatile functions in normal and cancer stem cells. , 2012, Frontiers in bioscience.

[39]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[40]  Pang-Kuo Lo,et al.  The effect of B27 supplement on promoting in vitro propagation of Her2/neu-transformed mammary tumorspheres , 2011 .

[41]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[42]  Zhuling Yang,et al.  Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma. , 2010, Cancer biomarkers : section A of Disease markers.

[43]  W. Dong,et al.  Expression of putative stem cell genes Musashi-1 and β1-integrin in human colorectal adenomas and adenocarcinomas , 2009, International Journal of Colorectal Disease.